Micro-anatomy related antigen expression in melanocytic lesions

Journal of Pathology

Volumn 190, Issue 5, 2000, Pages 572-578

  Meije, Clifton B ^a   Mooi, Wolter J ^b   Le Poole, I C ^a,e   Van Muijen, Goos N P ^c   Das, Pranab K ^a,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antigen expression; Dysplastic naevi; Melanocytic naevi; Melanoma metastases

Indexed keywords

GLYCOPROTEIN GP 100; HLA DR ANTIGEN; MELANOMA ANTIGEN; TYROSINASE RELATED PROTEIN 1;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; DYSPLASTIC NEVUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MELANOSOME; MICROSCOPIC ANATOMY; PRIORITY JOURNAL; SKIN PIGMENTATION;

ANTIGENS, NEOPLASM; CELL CULTURE TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; DYSPLASTIC NEVUS SYNDROME; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MELANOCYTES; MELANOMA; NEVUS, PIGMENTED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034028712     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200004)190:5<572::AID-PATH570>3.0.CO;2-9     Document Type: Article

References (28)

1. Ruiter DJ, Dingjan GM, Steijlen PM, et al. Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi. J Invest Dermatol 1985; 85: 4-8.
2. Carrel S. Schreyer M. Giuffre L. Melanoma associated differentiation antigens: investigation with monoclonal antibodies. Prog Clin Biol Res 1988; 256: 585-595.
3. Carrel S. Dore JF, Ruiter DJ, et al. The EORTC Melanoma Group exchange program: evaluation of a multicenter monoclonal antibody study. Int J Cancer 1991; 48: 836-847.
4. Clark WH Jr. Elder DE, Guerry D 4th. et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pthol 1984; 15: 1147-1165.
5. Carrel S, Rimoldi D. Melanoma-associated antigens. [Review] [44 refs]. Eur J Cancer 1993: 29A: 1903-1907.
6. Vennegoor C, Hageman P, Van Nouhuijs H, et al. A monoclonal antibody specific for cells of the melanocyte lineage. Am J Pathol 1988; 130: 179-192.
7. Thomson TM, Mattes MJ, Roux L, Old LJ, Lloyd KO. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J Invest Dermatol 1985; 85: 169-174.
8. Tomita Y, Montague PM, Hearing VJ. Anti-T4-tyrosinase monoclonal antibodies specific markers for pigmented melanoeytes. J Invest Dermatol 1985; 85: 426-430.
9. de Vries JE, Keizer GD, te Velde AA, et al. Characterization of melanoma-associated surface antigens involved in the adhesion and motilily of human melanoma cells. Int J Cancer 1986; 38: 465-473.
10. Adema GJ, de Boer AJ, Vogel AM, Loenen WA, Figdor CG. Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 1994; 269: 20126-20133.
11. Vijayasaradhi S, Houghton AN. Purification of an autoantigenic 75-kDa human melanosomal glycoprotein. Int J Cancer 1991; 47: 298-303.
12. Zhao H, Eling DJ, Medrano EE, Boissy RE, Retroviral infection with human tyrosinase-related protein-1 (TRP-1) cDNA upregulates tyrosinase activity and melanin synthesis in a TRP-1-deficient melanoma cell line. J Invest Dermatol 1996; 106: 744-752.
13. Cui J, Arita Y, Bystryn JC. Characterization of vitiligo antigens. Pigment Cell Res 1995; 8: 53-59.
14. Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993; 100: 816-822.
15. van Muijen GN, Cornelissen LM, Jansen CF, et al. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis 1991; 9: 259-272.
16. van Muijen GN, Jansen KF, Cornelissen IM, Smeets DF, Beck JL, Ruiter DJ. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 1991; 48: 85-91.
17. Krouwels FH, Nocker RE, Snoek M, et al. Immunocytochemical and flow cytofluorimetric detection of intracellular IL-4, IL-5 and JFN-gamma: applications using blood- and airway-derived cells. J Immunol Methods 1997; 203: 89-101.
18. Elder DE, Rodeck U, Thurin J, et al. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res 1989; 49: 5091-5096.
19. Tucker MA, Halpern A. Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma [see comments]. J Am Med Assoc 1997; 277: 1439-1444.
20. de Vries TJ, Fourkour A, Wobbes T, et al. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human mclanocytic lesions. Cancer Res 1997; 57: 3223-3229.
21. Natali PG, Bigotti A, Cavaliere R, Nicotra MR, Ferrone S. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. J Nat Cancer Inst 1984; 73: 13-24.
22. Krasagakis K, Garbe C, Kruger-Krasagakes S, Orfanos CE, 12-O-Tetradecanoylphorbol-13-acetate not only modulates proliferation rates, but also alters antigen expression and LAK-cell susceptibility of normal human melanocytes in vitro. J Invest Dermatol 1993; 100: 653-659.
23. Sviderskaya EV, Wakeling WF, Bennett DC. A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes. Development 1995; 121: 1547-1557.
24. Thomson TM, Real FX, Murakami S, Cordon-Cardo C, Old LJ, Houghton AN. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J Invest Dermatol 1988; 90: 459-466.
25. Tomita Y, Shibahara S, Takeda A, Okinaga S, Matsunaga J, Tagami H. The monoclonal antibodies TMH-1 and TMH-2 specifically bind to a protein encoded at the murine b-locus, not to the authentic tyrosinase encoded at the c-locus. J Invest Dermatol 1991; 96: 500-504.
26. Roddy VB, Gattuso P, Aranha G, Carson HJ. Cell proliferation markers in predicting metastases in malignant melanoma. J Cutan Pathol 1995; 22: 248-251.
27. Kuwata T, Kitagawa M, Kasuga T. Proliferative activity of primary cutaneous melanocytic tumours, Virchows Arch A [Pathol Anat Histopathol] 1993; 423: 359-364.
28. Woosley JT, Dietrich DR. Prognostic significance of PCNA grade in malignant melanoma. J Cutan Pathol 1993; 20: 498-503.